Skip to main content
Log in

Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Type 2 diabetic kidney disease (DKD) is the most common cause of end-stage renal failure, and the prevention of its progression has been a topic of discussion.

Methods

Sixty type 2 DKD patients were retrospectively evaluated for 1 year. Factors independently affecting the annual Ccr decline were examined by multivariable linear regression analysis. Patients were further divided into 2 groups based on their degree of renal function, and between-group differences at study initiation were evaluated.

Results

Ccr values were 21.0 ± 11.8 mL/min/1.73 m2 at study initiation, and 15.7 ± 10.9 mL/min/1.73 m2 after 1 year of observation. The multivariable linear regression analysis indicated salt intake (standardized coefficient: −0.34, P = 0.010) and urinary protein excretion (standardized coefficient: −0.33, P = 0.011) to be factors independently affecting the annual Ccr decline. Although decliners (−9.8 ± 4.7 mL/min/1.73 m2/year) had a significantly higher salt intake than non-decliners (−1.1 ± 3.8 mL/min/1.73 m2/year) at study initiation, this difference disappeared at the end of the study as a result of intensive dietary education. In 21 decliners with an additional year of follow-up, the annual Ccr decline significantly improved from −10.1 ± 5.3 to −5.3 ± 7.4 mL/min/1.73 m2/year (P = 0.02).

Conclusion

Salt intake and urinary protein excretion were associated with annual Ccr decline in type 2 DKD patients. Furthermore, dietary education covering salt intake may have positively affected the change in Ccr.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rotz E, Rychlik I, Locatelli F, Halimi S. End stage renal failure in type 2 diabetes: a medical catastrophe of world wide dimensions. Am J Kidney Dis. 1999;34:795–808.

    Article  Google Scholar 

  2. Byme C, Steenkamp R, Castledine C, Ansell D, Feehally J. UK renal registry 12th annual report: chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analysis. Nephron Clin Pract. 2010;115(Suppl 1):c41–67.

    Google Scholar 

  3. Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, et al. An overview of regular dialysis treatment in Japan. Ther Apher Dial. 2012;16:483–521.

    Article  PubMed  Google Scholar 

  4. Gall MA, Nielsen FS, Smidt UM, Parving HH. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia. 1993;36:1071–8.

    Article  CAS  PubMed  Google Scholar 

  5. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(Suppl 1):S11–61.

    Article  PubMed Central  Google Scholar 

  6. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66:1596–605.

    Article  PubMed  Google Scholar 

  7. Unsal A, Koc Y, Basturk T, Akgun AO, Sakaci T, Ahbap E. Risk factors for progression of renal disease in patient with diabetic nephropathy. Eur Rev Med Pharmacol Sci. 2012;16:878–83.

    CAS  PubMed  Google Scholar 

  8. Zoppini G, Targher G, Chonchol M, Ortalda V, Negri C, Stoico V, Bonora E. Predicted of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol. 2012;7:401–8.

    Article  CAS  PubMed  Google Scholar 

  9. Altemtam N, Russell J, Nahas ME. A study of the natural history of diabetic kidney disease (DKD). Nephrol Dial Transplant. 2012;27:1847–54.

    Article  CAS  PubMed  Google Scholar 

  10. Suckling RJ, He FJ, Macgregor GA. Alterd dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev. 2010;8:CD006763. doi:10. 1002/14651858. CD006763.pub2.

  11. Maroni BJ, Steinman TI, Mitch WE. A method for estimating nitrogen intake of patients with chronic renal failure. Kidney Int. 1985;27:58–65.

    Article  CAS  PubMed  Google Scholar 

  12. Japan Nephrology Society. Special issue. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Shi. 2012;54:1034–191.

    CAS  PubMed  Google Scholar 

  13. Maeda CY, Schaan BD, Oliveira E, Oliveira V, De Angelis KD, Irigoyen MC. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Clin Exp Pharmacol Physiol. 2007;34:574–80.

    Article  CAS  PubMed  Google Scholar 

  14. Keane WF, Brenner BM, de Zeeuw D, Grunfeld JP, Mcgrill J, Mitch WE, Ribeiro AB, Shahinfar S, Simpson RL, Snapinn SM, Toto R. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study. Kidney Int. 2003;63:1499–507.

    Article  PubMed  Google Scholar 

  15. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int. 2004;66:1596–605.

    Article  PubMed  Google Scholar 

  16. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int. 1990;38:384–94.

    Article  CAS  PubMed  Google Scholar 

  17. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;2007(25):1105–87.

    Article  Google Scholar 

  18. Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 2007;100:342–53.

    Article  CAS  PubMed  Google Scholar 

  19. Kobori H, Mori H, Masaki T, Nishiyama A. Angiotensin II blockade and renal protection. Curr Pharm Des. 2013;19:3033–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  21. Diamandopoulos A, Goudas P, Arvanitis A. Comparison of estimated creatinine clearance among five formulae (Cockroft–Gault, Jelliffe, Sanaka, simplified 4-variable MDRD and DAF) and the 24 h-urine-collection creatinine clearance. Hippokratia. 2010;14:98–104.

    PubMed Central  CAS  PubMed  Google Scholar 

  22. Dowling TC, Wang ES, Ferrucci L, Sorkin JD. Glomerular filtration rate equations overestimate creatinine clearance in older individuals enrolled in the Baltimore Longitudinal Study on aging: impact on renal drug dosing. Pharmacotherapy. 2013;33:912–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Dowling TC, Matzke GR, Murphy JE, Burckart GL. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacology. 2010;30:776–86.

    CAS  Google Scholar 

  24. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal disease: a meta-analysis. Ann Intern Med. 1996;124:627–32.

    Article  CAS  PubMed  Google Scholar 

  25. Koya D, Haneda M, Inomata S, Suzuki Y, Suzuki D, Makino H, Shikata K, Murakami Y, Tomino Y, Yamada K, Araki SI, Kashiwagi A, Kikkawa R. Low-protein diet study group. Long-term effect of modification of dietary protein intake on the progression of diabetic nephropathy: a randomized controlled trial. Diabetologia. 2009;52:2037–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Williams ME, Stanton R. Chapter 31-nutritional and metabolic management of the diabetic patients with chronic kidney disease and chronic renal failure. In: Kopple JD, Massry SG, Kalantar-Zadeh K, editors. Nutritional management of renal disease. 1st ed. Amsterdam: Elsevier; 2013. p. 485–502.

    Chapter  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Susumu Ookawara.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanauchi, N., Ookawara, S., Ito, K. et al. Factors affecting the progression of renal dysfunction and the importance of salt restriction in patients with type 2 diabetic kidney disease. Clin Exp Nephrol 19, 1120–1126 (2015). https://doi.org/10.1007/s10157-015-1118-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1118-y

Keywords

Navigation